Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria - Test2 - elhamkhani - TriplyDB

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

http://www.wikidata.org/entity/Q24201077

about

Antimalarial drug combinations for treating uncomplicated malaria in pregnancy Plasmodium falciparum drug resistance in Angola New developments in anti-malarial target candidate and product profiles A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.Monthly malaria chemoprevention shows potential in an area of very high, perennial malaria transmission Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community r Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.When and how to update systematic reviews: consensus and checklist.The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.Cochrane Column.Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.A randomized trial of the prophylactic activity of DSM265 against pre-erythrocytic Plasmodium falciparum controlled human malaria infection by mosquito bites and direct venous inoculation.Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis.Antimalarial Activity of Plant Metabolites.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania Methylene blue for treating malaria

P2860

Q24188103-CD676E83-FE2E-4F53-9892-2E4D80C72DD3 Q28075079-B3C21CFA-2EEA-47FD-9143-C01A2535B90F Q28468598-F857C6E6-E80B-41E0-A2A2-B417F3178376 Q34020818-D681EB1F-58CC-4FB5-9FE7-26C3A2FFEDFD Q34227179-DCF52215-2360-4575-8441-C580AEA33960 Q34299178-B098AD14-9CC0-4A75-965A-B55E963653FE Q35052961-21238D3C-B388-44E6-8366-42331655B064 Q35691730-C71B1B1F-3E72-4BEF-89C9-3F3FD4C1AAEB Q35746240-89AD76DD-B305-4E9F-8BD3-04A0854BBC65 Q35949631-E38F1575-4594-4EFE-9ADF-B3A5EBA428DF Q36125476-FCD02E16-CF47-4EF8-A6B8-3BD647BC3735 Q36328321-4A5260FB-C6B6-497C-9086-FCAC305A1C75 Q36436334-A25D6C2B-BB62-494E-9AF3-507F103A0575 Q36615103-2E11F73C-5DD1-4708-AD3E-475464588F72 Q36843561-C4E79066-55C2-42F3-BD76-F86067FAE542 Q37114403-0DB89A3C-42F4-4854-90B4-93210A8B7E8B Q37291543-8FE48BB2-AAAC-4ECD-B7BF-85EDADFA8AB7 Q37480626-3A926940-3A3B-48D5-9461-A8547937BCF0 Q37607325-603F9ABD-4EE7-4EAB-8592-56BDB66A22DC Q38642887-6009D600-A6B0-418C-B9DD-CAEC17985A79 Q38684764-E398BE88-7532-4D81-91E5-6D8589323FB0 Q38850820-E5867D2E-D8EA-4EA7-A860-6B57061FBF59 Q39599642-19F49E46-6E1D-4F88-B87F-2649C384B5D3 Q41947692-91362927-0333-4BFD-B425-FFB9EDB1F5C3 Q48018719-76F130C8-EDD0-427A-828E-4938706E82DE Q52615236-11ACCCC1-87F4-4415-AA9E-88D43FF18BA6 Q53702337-B2C3B86E-7557-4660-A588-554C98A4CA91 Q55113560-63756079-A90E-4405-8402-AB974DBC1670 Q56352635-59CF4E41-C375-424F-9F73-BB8F15726C5A Q56355681-962D97E9-2EE0-4FC9-B5CB-81EF8364AB56 Q56363463-5B4129E7-E613-456E-AED2-A1125225DBFC Q56785617-C116D6FF-9AAC-4C1F-B168-A31ED51419D7

P2860

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

http://www.wikidata.org/entity/Q24201077

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@ast

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en-gb

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@nl

type

label

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@ast

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en-gb

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@nl

prefLabel

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@ast

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en-gb

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@nl

P1433

Q24201077-CA3A484C-0723-4EB5-BF30-C863566AEEF8

P1476

Q24201077-D5C36D6B-E3E8-42AF-AD4B-6288D2264BD6

P2093

Q24201077-0864BA95-214A-45E9-930E-130BCC15DCC2

Q24201077-9A29DECE-D3A6-48DB-B03F-1D9C0641CD66

Q24201077-C8219762-7995-44A9-9907-31CDE4D950F4

P275

Q24201077-DFFE136C-BC85-4310-A08F-DFCA57A5D6DD

Q24201077-F36E4440-C4F8-4632-B8C6-0A4490796BDA

Q24201077-F97ECB8F-2BC8-41DE-B54C-4D3ECD1D86C4

P2860

Q24201077-025E7806-CBDC-46C1-990A-A92AB32E0D5A

Q24201077-053E7364-8A32-495F-865B-D8A60A6D398F

Q24201077-089BC128-C374-44B1-82EC-1560E731C031

Q24201077-0A212EF4-001E-4CEF-A659-3FF853A9BDE0

Q24201077-0E9D7DEB-492D-4839-8434-D566C3B90AC4

Q24201077-1548DDC5-9F3D-4DF4-ACD0-70777D016AF3

Q24201077-16F6585B-9316-4D91-B856-B6B486813722

Q24201077-185415AA-5F7E-4D44-9A5E-EE9A9E83006C

Q24201077-1D2F76FE-84CF-4E10-AD1B-1B2EB8E91AE0

Q24201077-276153E3-0672-497C-92B1-864692542EFB

P304

Q24201077-6E382EED-AD90-449C-8CDA-DE5ADF28CEC5

P31

Q24201077-440e54a7-5dd3-4124-833c-8d2170a7f9ac

Q24201077-562EA58C-2404-4FDB-AC9D-9766BF9C35F5

Q24201077-68C9089C-7B9F-40EA-809D-9A7A139562DD

P3181

Q24201077-14C70A25-D841-4E08-B9C2-031400B9C953

P356

Q24201077-451E25B7-A7AF-40D1-8ECA-8220090721AA

P407

Q24201077-5A14D608-28AA-40CB-8143-8A78CB0B6918

P433

Q24201077-96C0C31C-2EF3-4BF4-9FC1-DCCBE58F7420

P478

Q24201077-83FB8E4B-4403-46CA-AD08-5DF2956B49EA

P50

Q24201077-19D9405B-F9AA-44F4-ADC6-B3AFD6FC350D

Q24201077-D65DC6FB-058A-4B46-BBBE-E92B849D23A0

P5008

Q24201077-BA02E797-F4DD-4993-A04A-8D6AB1D65AAD

P577

Q24201077-9C8F8AB2-791E-480C-8929-1B5E83D527FB

P698

Q24201077-12441C42-45CE-4602-B65B-05A1CF5EA335

P921

Q24201077-19F2B0BD-5A67-4FD6-ABAD-20F6B2111142

Q24201077-449B23A2-E578-4C40-80C8-7C46B9AD16F0

Q24201077-A8437B2A-9F0D-4E92-A257-1009B5E253B3

Q24201077-BC29DDBB-8904-443C-B4A4-908C119BD2EB

Q24201077-C53F5FF0-5CAE-4ED8-8527-341D5072D1D4

Q24201077-EBB25A8B-2084-40EC-A6C2-3284DCB610C7

P932

Q24201077-22C845AC-3D52-4EFB-95AA-629E284C5482

P3181

P356

14651858.CD010927

P1433

Cochrane Database of Systematic Reviews

P1476

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

@en

P2093

David Sinclair

http://www.w3.org/2001/XMLSchema#string

Michael Gathu

http://www.w3.org/2001/XMLSchema#string

Piero L Olliaro

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

Creative Commons Attribution-NonCommercial

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit

Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries

Artesunate versus quinine for treating severe malaria

Artemisinin-based combination therapy for treating uncomplicated malaria

What is "quality of evidence" and why is it important to clinicians?

The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru

An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia

P304

CD010927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3322528

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD010927

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24443033

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum malaria

inorganic compound

heterocyclic compound

Plasmodium falciparum

P932

4470355

http://www.w3.org/2001/XMLSchema#string